The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group
- PMID: 1911205
- PMCID: PMC1977630
- DOI: 10.1038/bjc.1991.357
The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group
Erratum in
- Br J Cancer 1992 Apr;65(4):630
Abstract
Previous reports have suggested that the relationship between survival and thickness of primary cutaneous malignant melanoma is not linear, but that there are natural breakpoints at which survival worsens in a step fashion. Nine hundred and ninety-seven cases of primary cutaneous malignant melanoma less than 9.75 mm thick, excised in Scotland between 1979 and 1983 inclusive, were examined to see if this could be confirmed. An adjusted Cox's regression analysis showed that age, sex, site and thickness were all significant predictors of survival. Thickness was grouped either empirically or by the breakpoints reported by other authors. It was then entered into a model either as a regressor or as a factored variable. The ranges 0-9.75 mm and 0-2 mm were studied separately. In the 0-9.75 mm range the factored variable was a statistically significant better fit than the regressor for each set of breakpoints, including an empirical analysis with eight groups. This suggests that there is no single best fit and that a step-effect is unlikely. Across the 0-2 mm range there was no significant improvement in the fit if thickness was entered as a factored variable, again indicating that a step effect is unlikely. We argue that there is no biological or statistical evidence to support the existence of natural breakpoints.
Similar articles
-
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x. Br J Dermatol. 2004. PMID: 15030337
-
Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease.Cancer. 1988 Sep 15;62(6):1207-14. doi: 10.1002/1097-0142(19880915)62:6<1207::aid-cncr2820620628>3.0.co;2-a. Cancer. 1988. PMID: 3409189
-
Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.Virchows Arch A Pathol Anat Histopathol. 1985;406(2):179-95. doi: 10.1007/BF00737084. Virchows Arch A Pathol Anat Histopathol. 1985. PMID: 3923697
-
Action profiles of predictors of death and survival time in stage I malignant melanoma.Dermatology. 1996;192(1):1-7. doi: 10.1159/000246303. Dermatology. 1996. PMID: 8832942
-
p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.Br J Cancer. 1999 Feb;79(5-6):895-902. doi: 10.1038/sj.bjc.6690143. Br J Cancer. 1999. PMID: 10070887 Free PMC article.
Cited by
-
Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.Br J Cancer. 2008 Jan 15;98(1):39-44. doi: 10.1038/sj.bjc.6604120. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087287 Free PMC article.
-
Professor Rona MacKie, Scottish dermatologist and melanoma authority.Int J Womens Dermatol. 2015 Oct 1;1(4):187-190. doi: 10.1016/j.ijwd.2015.08.003. eCollection 2015 Dec. Int J Womens Dermatol. 2015. PMID: 28491989 Free PMC article. No abstract available.
-
[Histology of malignant tumors caused by UV light].Hautarzt. 2012 Oct;63(10):778-87. doi: 10.1007/s00105-012-2401-4. Hautarzt. 2012. PMID: 23052102 German.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical